BLOG

FDA Puts Clinical Trial for CRISPR Therapy on Hold – Labiotech.eu (blog)

Continue reading

2018-06-01 NEWS

MIT Technology Review

FDA Puts Clinical Trial for CRISPR Therapy on Hold
Labiotech.eu (blog)
The FDA has put a hold on CRISPR Therapeutics’ planned Phase I/II trial testing a CRISPR gene-editing therapy in patients with sickle cell disease. CRISPR Therapeutics, based in Basel, Switzerland, and its partner Vertex Pharmaceuticals will have to …
FDA halts one of the first human CRISPR studies before it beginsMIT Technology Review
The FDA Puts the Brakes on a Major CRISPR Trial in HumansFuturism
Is Crispr Therapeutics Stock a Bad News Buy?Motley Fool
Bloomberg –Xconomy –FierceBiotech –CRISPR | News Release – CRISPR Therapeutics
all 104 news articles »
Continue reading

2018-06-01 NEWS

MIT Technology Review

FDA Puts Clinical Trial for CRISPR Therapy on Hold
Labiotech.eu (blog)
The FDA has put a hold on CRISPR Therapeutics’ planned Phase I/II trial testing a CRISPR gene-editing therapy in patients with sickle cell disease. CRISPR Therapeutics, based in Basel, Switzerland, and its partner Vertex Pharmaceuticals will have to …
FDA halts one of the first human CRISPR studies before it beginsMIT Technology Review
The FDA Puts the Brakes on a Major CRISPR Trial in HumansFuturism
Is Crispr Therapeutics Stock a Bad News Buy?Motley Fool
Bloomberg –Xconomy –FierceBiotech –CRISPR | News Release – CRISPR Therapeutics
all 104 news articles »